Literature DB >> 16701143

Histamine receptors in immune regulation and allergen-specific immunotherapy.

Marek Jutel1, Kurt Blaser, Cezmi A Akdis.   

Abstract

The cells involved in the regulation of immune responses and hematopoiesis express histamine receptors and secrete histamine. Histamine acting through four types of its receptors has been shown not only to affect chronic inflammatory responses but also to regulate several essential events in the immune response. Histamine signals have a role in the mechanisms of tolerance induced during allergen-specific immunotherapy (SIT), acting mainly through its receptor (HR) type 2. It positively interferes with the peripheral antigen tolerance induced by T regulatory cells in several pathways. The rationale for the concomitant use of H1 antihistamines during SIT is diverse and includes reduction of its immediate side effects as well as enhancement of mechanisms of specific tolerance and anti-inflammatory effects of vaccination.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16701143     DOI: 10.1016/j.iac.2006.02.006

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  9 in total

1.  Histamine H4 receptor optimizes T regulatory cell frequency and facilitates anti-inflammatory responses within the central nervous system.

Authors:  Roxana del Rio; Rajkumar Noubade; Naresha Saligrama; Emma H Wall; Dimitry N Krementsov; Matthew E Poynter; James F Zachary; Robin L Thurmond; Cory Teuscher
Journal:  J Immunol       Date:  2011-12-05       Impact factor: 5.422

Review 2.  Dynamic scaling in chemical ecology.

Authors:  Richard K Zimmer; Cheryl Ann Zimmer
Journal:  J Chem Ecol       Date:  2008-06-03       Impact factor: 2.626

3.  Identification of potential crucial gene network related to seasonal allergic rhinitis using microarray data.

Authors:  Jun Shi; Ying Zhang; Shanshan Qi; Guanghui Liu; Xiang Dong; Nan Huang; Wenjing Li; Hao Chen; Bingmei Zhu
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-07-19       Impact factor: 2.503

4.  Cutting edge: histamine is required for IL-4-driven eosinophilic allergic responses.

Authors:  Julie A Swartzendruber; Adam J Byrne; Paul J Bryce
Journal:  J Immunol       Date:  2011-12-09       Impact factor: 5.422

5.  Prophylactic and Therapeutic Potential of Asp f1 Epitopes in Naïve and Sensitized BALB/c Mice.

Authors:  Neelkamal Chaudhary; Lakshna Mahajan; Taruna Madan; Anil Kumar; Gajendra Pratap Singh Raghava; Seturam Bandacharya Katti; Wahajul Haq; Puranam Usha Sarma
Journal:  Immune Netw       Date:  2009-10-30       Impact factor: 6.303

6.  Impact of allergic rhinitis and specific subcutaneous immunotherapy on peripheral blood basophils of patients sensitized to Dermatophagoides pteronyssinus.

Authors:  Ana Lopes; Patrícia Azenha; Cristina Teodósio; Maria Inácio; Isabel Silva; Graça Loureiro; António Martinho; António S Luís; Hélder Trindade; Celso Pereira; Artur Paiva
Journal:  Allergy Asthma Clin Immunol       Date:  2013-10-11       Impact factor: 3.406

7.  Ranitidine Inhibition of Breast Tumor Growth Is B Cell Dependent and Associated With an Enhanced Antitumor Antibody Response.

Authors:  Dakota Rogers; Ava Vila-Leahey; Ana Clara Pessôa; Sharon Oldford; Paola A Marignani; Jean S Marshall
Journal:  Front Immunol       Date:  2018-08-15       Impact factor: 7.561

8.  Ranitidine modifies myeloid cell populations and inhibits breast tumor development and spread in mice.

Authors:  Ava Vila-Leahey; Sharon A Oldford; Paola A Marignani; Jun Wang; Ian D Haidl; Jean S Marshall
Journal:  Oncoimmunology       Date:  2016-03-10       Impact factor: 8.110

9.  Differential expression of histamine receptors in the bladder wall tissues of patients with bladder pain syndrome/interstitial cystitis - significance in the responsiveness to antihistamine treatment and disease symptoms.

Authors:  Hui Shan; Er-Wei Zhang; Peng Zhang; Xiao-Dong Zhang; Ning Zhang; Peng Du; Yong Yang
Journal:  BMC Urol       Date:  2019-11-12       Impact factor: 2.264

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.